Article Tag: AgBiome

AgBiome, Inc. announced the next step in its partnership with Summit Agro Mexico, granting them exclusive distribution rights of Howler fungicide for Mexico. The move […]

Ben Holt has been appointed vice president for innovation with AgBiome. Holt will be responsible for developing partnership opportunities that leverage AgBiome’s technical platform, as […]

AgBiome has hired David Gilliam, southeast channel sales manager, to cover its Florida markets. Gilliam will be responsible for creating, building, and strengthening the company’s […]

AgBiome’s Esendo microbial-based fungicide has received approval from the US Environmental Protection Agency. The first of AgBiome’s proprietary Connate portfolio to receive approval from the […]

AgBiome has appointed Laura Potter as chief science officer; in this role, she will drive AgBiome's scientific strategy and innovative vision to leverage the company’s […]

AgBiome, Inc. is collaborating with W. L. Gore & Associates to discover and improve methods for growing commercially important microbes. This collaboration will bring together […]

AgBiome announces a strategic partnership with Dry Services, a natural product processing and packaging provider. This alliance will facilitate the production, scaling and packaging of […]

AgBiome, Inc., has been named a Certified B Corporation, or B Corp. AgBiome is among the first agricultural biotech organizations, and the only one with […]

AgBiome announced its newest product, Theia fungicide, has received approval from the US Environmental Protection Agency. Theia fungicide, developed through AgBiome’s GENESIS platform, is the […]

3Bar Biologics has partnered with AgBiome on non-spore forming bacterial strains to be evaluated in the LiveMicrobe technology platform. Through its GENESIS discovery platform, AgBiome […]

AgBiome has hired four strategic leaders across their organization. Chris Matton was appointed general counsel to oversee and provide support and counsel for AgBiome’s corporate […]

AgBiome has announced that it will receive phase 2 funding from the Bill & Melinda Gates Foundation for a project aimed to develop novel, efficacious, […]